The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Barriers to and clinical outcomes with next-generation sequencing testing in metastatic prostate cancer.
 
Madelyn Klugman
No Relationships to Disclose
 
Hua-Ling Tsai
No Relationships to Disclose
 
Yasaman Iranmanesh
No Relationships to Disclose
 
Ifeoma Nwig
No Relationships to Disclose
 
Laura Sena
Research Funding - Panbela Therapeutics (Inst)
 
Mario Eisenberger
Stock and Other Ownership Interests - Veru
Honoraria - Bayer; Merck Sharp & Dohme; Seagen
Travel, Accommodations, Expenses - Veru
 
Otis Brawley
Leadership - Agilent; Illumina; Incyte; Jackson Laboratory for Genomic Medicine; Lyell Immunopharma; PDS Biotechnology
Stock and Other Ownership Interests - Agilent; Incyte
Honoraria - AstraZeneca; Genentech/Roche; Grail
Consulting or Advisory Role - Genentech/Roche; Grail
Travel, Accommodations, Expenses - Genentech/Roche
 
Adel Mandl
Employment - EMD Serono (I)
 
Mark Markowski
No Relationships to Disclose
 
Emmanuel Antonarakis
Consulting or Advisory Role - AADi; AIkido Pharma; Amgen; AstraZeneca; Bayer (Inst); Blue Earth Diagnostics; Corcept Therapeutics; Curium Pharma; Foundation Medicine; Hookipa Pharma; Janssen Biotech; Lilly; Menarini Silicon Biosystems; Merck; Pfizer; Sanofi; Tango Therapeutics; Tempus; Z-Alpha
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Macrogenics (Inst); Merck (Inst); Orion Health (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
 
Channing Paller
Consulting or Advisory Role - AstraZeneca; Bayer; Dendreon; Exelixis; Janssen Oncology; Omnitura; Pfizer
Research Funding - Lilly (Inst)
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer
 
Samuel Denmeade
Research Funding - Astellas Pharma (Inst); Bayer
 
Michael Carducci
Honoraria - Remedica
Consulting or Advisory Role - Acrivon Therapeutics; Amgen; AstraZeneca; Pfizer
 
Jenna Canzoniero
Stock and Other Ownership Interests - ROM Tech
Honoraria - Conexient; MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Illumina
Patents, Royalties, Other Intellectual Property - Patent 63/548,318
(OPTIONAL) Uncompensated Relationships - Foundation Medicine
 
Kala Visvanathan
Honoraria - EvolveImmune Therapeutics
Research Funding - Cepheid (Inst); Optra Health Inc (Inst)
Patents, Royalties, Other Intellectual Property - Licensing of patent with Cepheid (Inst)
(OPTIONAL) Uncompensated Relationships - Optra Health
 
Catherine Marshall
Honoraria - Tempus
Consulting or Advisory Role - Bayer; Dendreon; McGraw-Hill Education; Obseva
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - McGraw Hill - textbook royalties
Travel, Accommodations, Expenses - Bayer